Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
Aim. To describe best practices in using human normal immunoglobulin in patients with immune-mediated neurological disorders according to the data of one clinical center. Materials and methods. From 2016 to 2021, 20 patients with various autoimmune disorders of the peripheral and central nervous sys...
Saved in:
Published in | Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny Vol. 22; no. 1; pp. 174 - 182 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.01.2023
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!